Impax Laboratories (IPXL): Amneal deal coming today? - RBC
RBC Capital analyst, Randall Stanicky, reiterated his Sector Perform rating on shares of Impax Laboratories (NASDAQ: IPXL) after WSJ reported ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
